Fatal post-viral neurodegenerative disorder

Overview

Diagnosis

Management

Special Populations

Key Recommendations

References

Showing 100 most recent of 223 indexed papers.

1 Danzer KM, Sparrer KM. Could targeting viruses be a new hope against neurodegenerative diseases?. PLoS biology 2026. link 2 Kwaśniewska K, Fic W, Polak-Szczybyło E. Vitamins as Modulators of Neurodegenerative Disease Pathways: Mechanisms and Therapeutic Perspectives. Nutrients 2026. link 3 Atasever E, Cebe T, Turgut Ş, Andican G, Çakatay U. Cytoskeletal disintegration in cardiovascular disease-related neurodegeneration. Advances in protein chemistry and structural biology 2026. link 4 Li L, Guo YD, Zhang XW, Du ZY, Wang YQ, Yang Z et al.. Targeting G3BP1 Condensate Topology Promotes Stress Granule Assembly via m. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 2026. link 5 Wang M, Ghazal R, Srinivas AN, Nguyen TTL, Murthy V, McNamara DM et al.. Novel association of . American journal of physiology. Heart and circulatory physiology 2026. link 6 Jiang M, Chi J, Qiao Y, Wang J, Zhang Z, Liu J et al.. Ginsenosides Rg1, Rb1 and rare ginsenosides: Promising candidate agents for Parkinson's disease and Alzheimer's disease and network pharmacology analysis. Pharmacological research 2025. link 7 Servick K. Could adding light sensors to nerve cells help switch off diseases?. Science (New York, N.Y.) 2025. link 8 Saija C, Currò M, Ientile R, Caccamo D, Bertuccio MP. Impact of Alterations in Homocysteine, Asymmetric Dimethylarginine and Vitamins-Related Pathways in Some Neurodegenerative Diseases: A Narrative Review. International journal of molecular sciences 2025. link 9 Zhao WB, Sheng R. The correlation between mitochondria-associated endoplasmic reticulum membranes (MAMs) and Ca. Acta pharmacologica Sinica 2025. link 10 Carney RP, Mizenko RR, Bozkurt BT, Lowe N, Henson T, Arizzi A et al.. Harnessing extracellular vesicle heterogeneity for diagnostic and therapeutic applications. Nature nanotechnology 2025. link 11 Mao Y, Feng J. Phosphatase activity-based PPM1K: a key player in the regulation of mitochondrial function and its multifaceted impact in diseases. Molecular and cellular biochemistry 2025. link 12 Beura SK, Panigrahi AR, Yadav P, Kulkarni PP, Lakhanpal V, Singh B et al.. Role of Thrombosis in Neurodegenerative Diseases: An Intricate Mechanism of Neurovascular Complications. Molecular neurobiology 2025. link 13 Yan L, Xu K, Liu C, Yu F, Guo J, Hou L et al.. Polymer-Formulated Nerve Growth Factor Shows Effective Therapeutic Efficacy for Cerebral Microinfarcts. Advanced materials (Deerfield Beach, Fla.) 2025. link 14 Wang X, Zhu K, Wu W, Zhou D, Lu H, Du J et al.. Prevalence of mixed neuropathologies in age-related neurodegenerative diseases: A community-based autopsy study in China. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025. link 15 Brown A, Lam L, Huh B, D'Souza RS, Javed S. Atypical Applications of Neuromodulation for Non-Painful Conditions. Current pain and headache reports 2025. link 16 Singulani MP, Ferreira AFF, Figueroa PS, Cuyul-Vásquez I, Talib LL, Britto LR et al.. Lithium and disease modification: A systematic review and meta-analysis in Alzheimer's and Parkinson's disease. Ageing research reviews 2024. link 17 Perry SE, Troche M, Huber JE, Curtis J, Kiefer B, Sevitz J et al.. Behavioral Management of Respiratory/Phonatory Dysfunction for Dysarthria Associated With Neurodegenerative Disease: A Systematic Review. American journal of speech-language pathology 2024. link 18 Aamodt WW, Sun C, Dahodwala N, Elser H, Schneider ALC, Farrar JT et al.. End-of-Life Health Care Service Use and Cost Among Medicare Decedents With Neurodegenerative Diseases. Neurology 2024. link 19 Li F, Wu C, Wang G. Targeting NAD Metabolism for the Therapy of Age-Related Neurodegenerative Diseases. Neuroscience bulletin 2024. link 20 Shi R, Gao D, Stoika R, Liu K, Sik A, Jin M. Potential implications of polyphenolic compounds in neurodegenerative diseases. Critical reviews in food science and nutrition 2024. link 21 Drenthen GS, Elschot EP, van der Knaap N, Uher D, Voorter PHM, Backes WH et al.. Imaging Interstitial Fluid With MRI: A Narrative Review on the Associations of Altered Interstitial Fluid With Vascular and Neurodegenerative Abnormalities. Journal of magnetic resonance imaging : JMRI 2024. link 22 Sanchez E, Wilkinson T, Coughlan G, Mirza S, Baril AA, Ramirez J et al.. Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative. Alzheimer's & dementia : the journal of the Alzheimer's Association 2024. link 23 Sabeva N, Castro W, Acosta YF, Ferchmin PA, Eterović VA, Sierra-Mercado D et al.. Determining the safety of the tobacco cembranoid (1S,2E,4R,6R,7E,11E)-Cembratriene-4,6-diol (4R): A translational study in nonhuman primates. Toxicology and applied pharmacology 2024. link 24 Saçmacı H, Çakır M, Özcan SS. Adropin and MOTS-c as new peptides: Do levels change in neurodegenerative diseases and ischemic stroke?. Journal of biochemical and molecular toxicology 2023. link 25 Forrest SL, Kovacs GG. Current Concepts of Mixed Pathologies in Neurodegenerative Diseases. The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques 2023. link 26 Auerbacher M, Gebetsberger L, Kaisarly D, Schmidmaier R, Hickel R, Drey M. Oral health in patients with neurodegenerative and cerebrovascular disease: a retrospective study. Disability and rehabilitation 2023. link 27 Xuan W, Xie W, Li F, Huang D, Zhu Z, Lin Y et al.. Dualistic roles and mechanistic insights of macrophage migration inhibitory factor in brain injury and neurodegenerative diseases. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2023. link 28 Pandey S, Shen K, Lee SH, Shen YA, Wang Y, Otero-García M et al.. Disease-associated oligodendrocyte responses across neurodegenerative diseases. Cell reports 2022. link 29 Nabizadeh F, Nikfarjam M, Azami M, Sharifkazemi H, Sodeifian F. Pseudobulbar affect in neurodegenerative diseases: A systematic review and meta-analysis. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2022. link 30 Patil AD, Biousse V, Newman NJ. Artificial intelligence in ophthalmology: an insight into neurodegenerative disease. Current opinion in ophthalmology 2022. link 31 Hoffman JM, Hernandez CM, Hernandez AR, Bizon JL, Burke SN, Carter CS et al.. Bridging the Gap: A Geroscience Primer for Neuroscientists With Potential Collaborative Applications. The journals of gerontology. Series A, Biological sciences and medical sciences 2022. link 32 Plys E, Vaughan CL, Kutner JS, Berk J, Kolva E. Interdisciplinary neuropalliative care: A unique and valuable clinical training experience for geropsychology trainees. Gerontology & geriatrics education 2022. link 33 Kumar RR, Singh L, Thakur A, Singh S, Kumar B. Role of Vitamins in Neurodegenerative Diseases: A Review. CNS & neurological disorders drug targets 2022. link 34 Chen Y, Liu Q, Liu J, Wei P, Li B, Wang N et al.. Revealing the Modular Similarities and Differences Among Alzheimer's Disease, Vascular Dementia, and Parkinson's Disease in Genomic Networks. Neuromolecular medicine 2022. link 35 Godkin FE, Turner E, Demnati Y, Vert A, Roberts A, Swartz RH et al.. Feasibility of a continuous, multi-sensor remote health monitoring approach in persons living with neurodegenerative disease. Journal of neurology 2022. link 36 Liu ZY, Zhai FF, Ao DH, Han F, Li ML, Zhou L et al.. Deep medullary veins are associated with widespread brain structural abnormalities. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2022. link 37 Weninger G, Pochechueva T, El Chami D, Luo X, Kohl T, Brandenburg S et al.. Calpain cleavage of Junctophilin-2 generates a spectrum of calcium-dependent cleavage products and DNA-rich NT. Scientific reports 2022. link 38 Nurmi SM, Halkoaho A, Moilanen J, Remes AM, Solje E. The ethical implications of genetic testing in neurodegenerative diseases: A systematic review. Scandinavian journal of caring sciences 2021. link 39 . Ishmail Abdus-Saboor. Neuron 2021. link 40 Ostojic SM, Ratgeber L, Olah A, Betlehem J, Pongras A. What do over-trained athletes and patients with neurodegenerative diseases have in common? Mitochondrial dysfunction. Experimental biology and medicine (Maywood, N.J.) 2021. link 41 Hamedani AG. Vision loss and hallucinations: perspectives from neurology and ophthalmology. Current opinion in neurology 2021. link 42 Calabrese EJ, Agathokleous E, Calabrese V. Ferulic acid and hormesis: Biomedical and environmental implications. Mechanisms of ageing and development 2021. link 43 Rüsch CT, Wortmann SB, Kovacs-Nagy R, Grehten P, Häberle J, Latal B et al.. Thiamine Pyrophosphokinase Deficiency due to Mutations in the TPK1 Gene: A Rare, Treatable Neurodegenerative Disorder. Neuropediatrics 2021. link 44 Ito H, Kurokawa H, Matsui H. Mitochondrial reactive oxygen species and heme, non-heme iron metabolism. Archives of biochemistry and biophysics 2021. link 45 Chatterji A, Sengupta R. Cellular S-denitrosylases: Potential role and interplay of Thioredoxin, TRP14, and Glutaredoxin systems in thiol-dependent protein denitrosylation. The international journal of biochemistry & cell biology 2021. link 46 Lee SY, Chung WS. The roles of astrocytic phagocytosis in maintaining homeostasis of brains. Journal of pharmacological sciences 2021. link 47 Wang Y, Yang Y, Zhang S, Li C, Zhang L. Modulation of neuroinflammation by cysteinyl leukotriene 1 and 2 receptors: implications for cerebral ischemia and neurodegenerative diseases. Neurobiology of aging 2020. link 48 Barbagallo C, Mostile G, Baglieri G, Giunta F, Luca A, Raciti L et al.. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases. Cellular and molecular neurobiology 2020. link 49 Soyal SM, Bonova P, Kwik M, Zara G, Auer S, Scharler C et al.. The Expression of CNS-Specific PPARGC1A Transcripts Is Regulated by Hypoxia and a Variable GT Repeat Polymorphism. Molecular neurobiology 2020. link 50 Amin F, Khan MS, Bano B. Mammalian cystatin and protagonists in brain diseases. Journal of biomolecular structure & dynamics 2020. link 51 Selvackadunco S, Langford K, Shah Z, Hurley S, Bodi I, King A et al.. Comparison of clinical and neuropathological diagnoses of neurodegenerative diseases in two centres from the Brains for Dementia Research (BDR) cohort. Journal of neural transmission (Vienna, Austria : 1996) 2019. link 52 DeKosky ST, Asthana S. The evolution of geriatric neurology. Handbook of clinical neurology 2019. link 53 Li W, Ma Y, Li Z, Lv X, Wang X, Zhou D et al.. Folic Acid Decreases Astrocyte Apoptosis by Preventing Oxidative Stress-Induced Telomere Attrition. International journal of molecular sciences 2019. link 54 Guo S, Deng W, Xing C, Zhou Y, Ning M, Lo EH. Effects of aging, hypertension and diabetes on the mouse brain and heart vasculomes. Neurobiology of disease 2019. link 55 Lo Van A, Sakayori N, Hachem M, Belkouch M, Picq M, Fourmaux B et al.. Targeting the Brain with a Neuroprotective Omega-3 Fatty Acid to Enhance Neurogenesis in Hypoxic Condition in Culture. Molecular neurobiology 2019. link 56 Abbas Q, Jafri SK, Ishaque S, Rahman AJ. Brown-Vialetto-Van Laere syndrome: a novel diagnosis to a common presentation. BMJ case reports 2018. link 57 Tan Z, Chen Y, Xie W, Liu X, Zhu Y, Zhu Y. Nimodipine attenuates tau phosphorylation at Ser396 via miR-132/GSK-3β pathway in chronic cerebral hypoperfusion rats. European journal of pharmacology 2018. link 58 Anzell AR, Maizy R, Przyklenk K, Sanderson TH. Mitochondrial Quality Control and Disease: Insights into Ischemia-Reperfusion Injury. Molecular neurobiology 2018. link 59 Morimoto BH. Therapeutic peptides for CNS indications: Progress and challenges. Bioorganic & medicinal chemistry 2018. link 60 Krajnak K, Dahl R. Small molecule SUMOylation activators are novel neuroprotective agents. Bioorganic & medicinal chemistry letters 2018. link 61 Bansal R, Singh R. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review. Medicinal research reviews 2018. link 62 Gurung AB, Bhattacharjee A. Impact of tyrosine nitration at positions Tyr307 and Tyr335 on structural dynamics of Lipoprotein-associated phospholipase A. International journal of biological macromolecules 2018. link 63 Kreider RB, Kalman DS, Antonio J, Ziegenfuss TN, Wildman R, Collins R et al.. International Society of Sports Nutrition position stand: safety and efficacy of creatine supplementation in exercise, sport, and medicine. Journal of the International Society of Sports Nutrition 2017. link 64 Liu QS, Li SR, Li K, Li X, Yin X, Pang Z. Ellagic acid improves endogenous neural stem cells proliferation and neurorestoration through Wnt/β-catenin signaling in vivo and in vitro. Molecular nutrition & food research 2017. link 65 Graham SH, Liu H. Life and death in the trash heap: The ubiquitin proteasome pathway and UCHL1 in brain aging, neurodegenerative disease and cerebral Ischemia. Ageing research reviews 2017. link 66 Wang Y, Ji X, Leak RK, Chen F, Cao G. Stem cell therapies in age-related neurodegenerative diseases and stroke. Ageing research reviews 2017. link 67 Majewski M, Kozlowska A, Thoene M, Lepiarczyk E, Grzegorzewski WJ. Overview of the role of vitamins and minerals on the kynurenine pathway in health and disease. Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 2016. link 68 Burnstock G. An introduction to the roles of purinergic signalling in neurodegeneration, neuroprotection and neuroregeneration. Neuropharmacology 2016. link 69 Simon MJ, Iliff JJ. Regulation of cerebrospinal fluid (CSF) flow in neurodegenerative, neurovascular and neuroinflammatory disease. Biochimica et biophysica acta 2016. link 70 Backes H, Walberer M, Ladwig A, Rueger MA, Neumaier B, Endepols H et al.. Glucose consumption of inflammatory cells masks metabolic deficits in the brain. NeuroImage 2016. link 71 Leng T, Liu A, Wang Y, Chen X, Zhou S, Li Q et al.. Naturally occurring marine steroid 24-methylenecholestane-3β,5α,6β,19-tetraol functions as a novel neuroprotectant. Steroids 2016. link 72 Wang M, Li YJ, Ding Y, Zhang HN, Sun T, Zhang K et al.. Silibinin Prevents Autophagic Cell Death upon Oxidative Stress in Cortical Neurons and Cerebral Ischemia-Reperfusion Injury. Molecular neurobiology 2016. link 73 Jarrott B, Williams SJ. Chronic Brain Inflammation: The Neurochemical Basis for Drugs to Reduce Inflammation. Neurochemical research 2016. link 74 Mattson MP. WHAT DOESN"T KILL YOU. Scientific American 2015. link 75 Fried-Oken M, Mooney A, Peters B. Supporting communication for patients with neurodegenerative disease. NeuroRehabilitation 2015. link 76 Stabenau HF, Morrison LJ, Gahbauer EA, Leo-Summers L, Allore HG, Gill TM. Functional trajectories in the year before hospice. Annals of family medicine 2015. link 77 Choi DY, Choi H. Natural products from marine organisms with neuroprotective activity in the experimental models of Alzheimer's disease, Parkinson's disease and ischemic brain stroke: their molecular targets and action mechanisms. Archives of pharmacal research 2015. link 78 Healy E. Autobiography: Kinuko Suzuki, MD. Journal of neuropathology and experimental neurology 2014. link 79 Steinman L. Why are prions and amyloid structures immune suppressive and other intriguing questions facing neuroimmunologists in the future. Revue neurologique 2014. link 80 Chu XP, Grasing KA, Wang JQ. Acid-sensing ion channels contribute to neurotoxicity. Translational stroke research 2014. link 81 Harish G, Venkateshappa C, Mahadevan A, Pruthi N, Bharath MM, Shankar SK. Mitochondrial function in human brains is affected by pre- and post mortem factors. Neuropathology and applied neurobiology 2013. link 82 Höschl C. Bedrich Smetana - art and disease. Psychiatria Danubina 2012. link 83 Umahara T, Uchihara T, Iwamoto T. Structure-oriented review of 14-3-3 protein isoforms in geriatric neuroscience. Geriatrics & gerontology international 2012. link 84 Lynch MA, Mills KH. Immunology meets neuroscience--opportunities for immune intervention in neurodegenerative diseases. Brain, behavior, and immunity 2012. link 85 Cristalli DO, Arnal N, Marra FA, de Alaniz MJ, Marra CA. Peripheral markers in neurodegenerative patients and their first-degree relatives. Journal of the neurological sciences 2012. link 86 Marklová E, Albahri Z, Vališ M. Microheterogeneity of some serum glycoproteins in neurodegenerative diseases. Journal of the neurological sciences 2012. link 87 Puyal J, Ginet V, Grishchuk Y, Truttmann AC, Clarke PG. Neuronal autophagy as a mediator of life and death: contrasting roles in chronic neurodegenerative and acute neural disorders. The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry 2012. link 88 Raghavan A, Shah ZA. Sirtuins in neurodegenerative diseases: a biological-chemical perspective. Neuro-degenerative diseases 2012. link 89 Stone TW, Forrest CM, Stoy N, Darlington LG. Involvement of kynurenines in Huntington's disease and stroke-induced brain damage. Journal of neural transmission (Vienna, Austria : 1996) 2012. link 90 Kaume L, Howard LR, Devareddy L. The blackberry fruit: a review on its composition and chemistry, metabolism and bioavailability, and health benefits. Journal of agricultural and food chemistry 2012. link 91 Uchihara T. Expanding morphological dimensions in neuropathology, from sequence biology to pathological sequences and clinical consequences. Neuropathology : official journal of the Japanese Society of Neuropathology 2011. link 92 Northrop NA, Yamamoto BK. Neuroimmune pharmacology from a neuroscience perspective. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2011. link 93 Buch SJ. Neuroimmune pharmacology as an emerging curriculum for pre-medical students. Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology 2011. link 94 Gray D. About the lecture by a physician. Journal of pain & palliative care pharmacotherapy 2011. link 95 Gowran A, Noonan J, Campbell VA. The multiplicity of action of cannabinoids: implications for treating neurodegeneration. CNS neuroscience & therapeutics 2011. link 96 Liu H, Li W, Ahmad M, Miller TM, Rose ME, Poloyac SM et al.. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiology of disease 2011. link 97 Matute C. Therapeutic potential of kainate receptors. CNS neuroscience & therapeutics 2011. link 98 Trompet S, de Craen AJ, Jukema JW, Pons D, Slagboom PE, Kremer D et al.. Variation in the CBP gene involved in epigenetic control associates with cognitive function. Neurobiology of aging 2011. link 99 Schiffer D. The history of neuropathology in Italy. Clinical neuropathology 2010. link 100 Armstrong RA. Review paper. Quantitative methods in neuropathology. Folia neuropathologica 2010. link